2007-04-19T00:00:00
Cancer Research UK has highlighted a study published in the Lancet that has found women who take hormone replacement therapy are more likely to be diagnosed with ovarian cancer and to die of the disease.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud